HOME

Independent Investor

Your next step towards being financially independent

Become a Member Now
Learn More

Take control of your financial future and become the master of your own investment decisions

Monthly Macro Report

  • A rundown of the current market environment and what that means for investors
  • Make wise investment desicions based on macro indicators
  • Our Chart of the Month highlighting a key macro signal

Monthly Equity Report

  • 50 high-quality, high-growth, and inexpensive stocks from our database of 25,000+ companies
  • One of our favorite stocks each month
  • Our daily newsletter to keep you informed on interesting market and company-specific insights

Investor's Timetable

  • A strategic investment framework to help you allocate your assets and investments
  • A monthly report that helps you adjust your allocations based on the changing economic environment.
  • Make informed investment choices that are tailored to their specific goals and needs.

Independent Investor Academy

  • Comprehensive educational resource for mastering the Investor's Timetable framework.
  • Classes, event recordings, and more to improve financial knowledge and skills.
  • Expert guidance and support for achieving financial goals.
Get Access Now

Latest Equity Report:

Regeneron Pharmaceuticals (REGN) - A drug development platform poised for further success

The market thinks this biotech giants heyday is coming to an end, but the firm has another blockbuster ready to take the reins and a strong pipeline and investment firepower signals more growth can come. 

Access the Full Report

About Us
Independent Investor is a membership based community with access to research powered by the proprietary UAFRS framework. Thanks to our partnerships we offer no-nonsense opinions and recommendations, industry expertise, and proven, back-tested data

© 2023 Independent Investor. All rights reserved.  Contact Us | Disclaimer | Terms of Use | Privacy Policy

Linkedin-in

Content Access Denied

The content you are trying to access is not included in your type of subscription to the Independent Investor database. 

Upgrade Now

Please fill out the fields below so that our client relations team can contact you